What is the performance of non-invasive fibrosis scores in non-alcoholic fatty liver disease in obese patients?
Background: Obesity has become a growing health concern and is a major risk factor for nonalcoholicfatty liver disease (NAFLD). The availability of an accurate diagnostictool is Essential to prevent the progression of fibrosis, cirrhosis, and hepatocellularcarcinoma. We aimed to evaluate the clinical and predictiveutility of non invasivescores of fibrosisscore in obeseand morbidly obesepatients with NAFLD. Methods: A total of 150 patients with BMI>30 kg/m2 andwithout a known liver diseaseare included in this prospective study.